News
03-18-2010, 05:30 AM
Celsion Corporation today announced that an abstract about the Phase I/II trial of ThermoDox® in Recurrent Chest Wall Cancer (RCW) has been accepted for presentation at the American Society of Clinical Oncology 2010 Annual Meeting.
More... (http://www.news-medical.net/news/20100318/Abstract-about-Phase-III-trial-of-ThermoDox-in-RCW-accepted-for-presentation-at-ASCO-2010.aspx)
More... (http://www.news-medical.net/news/20100318/Abstract-about-Phase-III-trial-of-ThermoDox-in-RCW-accepted-for-presentation-at-ASCO-2010.aspx)